/PRNewswire/ Panaxia Labs Israel Ltd. ("Panaxia Israel"), (TASE: PNAX), a global pharma company, specializes in developing, manufacturing and marketing.
Panaxia & AxioNovo GmbH will market cannabis-based products in Germany prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
( Panaxia Israel ) (TASE: PNAX),
Israel s largest medical cannabis company and a global company with activity in Germany, France, Israel, Cyprus, Greece and Malta, today published its financial results for the first quarter of 2021.
Panaxia Israel - revenues in millions: 2019-2021 quarterly revenues
Dadi Segal, CEO of Panaxia Israel, said, We are delighted to cap another record quarter of strong growth in revenues, which for the first time include retail sales of Panaxia products in Germany and Cyprus, along with a significant decrease in operating and net losses. As the only company in Israel with EU-GMP certification from the EU Health Authority, which is required to export to Europe, Panaxia is currently focused on implementing its global strategy and a gradual shift to development, production and export of its brands to the premium markets that are characterized by high profitability and a small number of competitors, and on exclusive partnerships with global pharmac
Share this article
Share this article
ATHENS and TEL AVIV, Israel, May 19, 2021 /PRNewswire/ Panaxia Labs Israel, Ltd. (Panaxia Israel) (TASE: PNAX), Israel s leading medical cannabis products manufacturer and Leriva Group, one of Greece s leading distributors of medical equipment, medical supplies and health services, announced today, Wednesday May 19, 2021, a binding agreement of manufacture, commercialization and distribution of medical cannabis finished products, developed by Panaxia for medical cannabis patients in Greece.
Under the agreement,
Panaxia will be responsible for registering the products, while complying with the European standard requirements, including EU-GMP; developing and manufacturing new and advanced products, including tablets, suppositories (candles) and inhalation products.
Panaxia and Leriva announced: Exclusive collaborations in Greece prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.